216 related articles for article (PubMed ID: 20860702)
1. Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging.
Boger HA; Mannangatti P; Samuvel DJ; Saylor AJ; Bender TS; McGinty JF; Fortress AM; Zaman V; Huang P; Middaugh LD; Randall PK; Jayanthi LD; Rohrer B; Helke KL; Granholm AC; Ramamoorthy S
Genes Brain Behav; 2011 Mar; 10(2):186-98. PubMed ID: 20860702
[TBL] [Abstract][Full Text] [Related]
2. Effect of the sonic hedgehog receptor smoothened on the survival and function of dopaminergic neurons.
Zhou X; Pace J; Filichia E; Lv T; Davis B; Hoffer B; Selman W; Luo Y
Exp Neurol; 2016 Sep; 283(Pt A):235-45. PubMed ID: 27317298
[TBL] [Abstract][Full Text] [Related]
3. Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of α-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice.
Sathiya S; Ranju V; Kalaivani P; Priya RJ; Sumathy H; Sunil AG; Babu CS
Neuropharmacology; 2013 Oct; 73():98-110. PubMed ID: 23747572
[TBL] [Abstract][Full Text] [Related]
4. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
[TBL] [Abstract][Full Text] [Related]
5. BDNF heterozygous mice demonstrate age-related changes in striatal and nigral gene expression.
Saylor AJ; Meredith GE; Vercillo MS; Zahm DS; McGinty JF
Exp Neurol; 2006 Jun; 199(2):362-72. PubMed ID: 16478623
[TBL] [Abstract][Full Text] [Related]
6. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.
Hung HC; Lee EH
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930
[TBL] [Abstract][Full Text] [Related]
7. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.
Longo F; Mercatelli D; Novello S; Arcuri L; Brugnoli A; Vincenzi F; Russo I; Berti G; Mabrouk OS; Kennedy RT; Shimshek DR; Varani K; Bubacco L; Greggio E; Morari M
Acta Neuropathol Commun; 2017 Mar; 5(1):22. PubMed ID: 28292328
[TBL] [Abstract][Full Text] [Related]
8. A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra.
Boger HA; Middaugh LD; Huang P; Zaman V; Smith AC; Hoffer BJ; Tomac AC; Granholm AC
Exp Neurol; 2006 Dec; 202(2):336-47. PubMed ID: 16889771
[TBL] [Abstract][Full Text] [Related]
9. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
[TBL] [Abstract][Full Text] [Related]
10. Modulation of nigrostriatal dopaminergic transmission by antisense oligodeoxynucleotide against brain-derived neurotrophic factor.
Lau YS; Hao R; Fung YK; Fu LS; Bishop JF; Pfeiffer RF; Mouradian MM
Neurochem Res; 1998 Apr; 23(4):525-32. PubMed ID: 9566587
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.
Al-Sweidi S; Morissette M; Bourque M; Di Paolo T
Neuropharmacology; 2011 Sep; 61(4):583-91. PubMed ID: 21586296
[TBL] [Abstract][Full Text] [Related]
12. Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity.
Gaugler MN; Genc O; Bobela W; Mohanna S; Ardah MT; El-Agnaf OM; Cantoni M; Bensadoun JC; Schneggenburger R; Knott GW; Aebischer P; Schneider BL
Acta Neuropathol; 2012 May; 123(5):653-69. PubMed ID: 22361813
[TBL] [Abstract][Full Text] [Related]
13. Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway.
Wu SY; Wang TF; Yu L; Jen CJ; Chuang JI; Wu FS; Wu CW; Kuo YM
Brain Behav Immun; 2011 Jan; 25(1):135-46. PubMed ID: 20851176
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta.
Baquet ZC; Bickford PC; Jones KR
J Neurosci; 2005 Jun; 25(26):6251-9. PubMed ID: 15987955
[TBL] [Abstract][Full Text] [Related]
15. Age-related changes in nigrostriatal dopaminergic function are accentuated in +/- brain-derived neurotrophic factor mice.
Dluzen DE; McDermott JL; Anderson LI; Kucera J; Joyce JN; Osredkar T; Walro JM
Neuroscience; 2004; 128(1):201-8. PubMed ID: 15450367
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes.
Midde NM; Gomez AM; Zhu J
J Neuroimmune Pharmacol; 2012 Sep; 7(3):629-39. PubMed ID: 22570010
[TBL] [Abstract][Full Text] [Related]
17. The Role of Biogenic Amine Transporters in Trace Amine-Associated Receptor 1 Regulation of Methamphetamine-Induced Neurotoxicity.
Miner NB; Phillips TJ; Janowsky A
J Pharmacol Exp Ther; 2019 Oct; 371(1):36-44. PubMed ID: 31320495
[TBL] [Abstract][Full Text] [Related]
18. Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease.
Colebrooke RE; Humby T; Lynch PJ; McGowan DP; Xia J; Emson PC
Eur J Neurosci; 2006 Nov; 24(9):2622-30. PubMed ID: 17100850
[TBL] [Abstract][Full Text] [Related]
19. Opposing effects of APP/PS1 and TrkB.T1 genotypes on midbrain dopamine neurons and stimulated dopamine release in vivo.
Kärkkäinen E; Yavich L; Miettinen PO; Tanila H
Brain Res; 2015 Oct; 1622():452-65. PubMed ID: 26168899
[TBL] [Abstract][Full Text] [Related]
20. Striatal dopamine output is compromised within +/- BDNF mice.
Dluzen DE; Anderson LI; McDermott JL; Kucera J; Walro JM
Synapse; 2002 Feb; 43(2):112-7. PubMed ID: 11754489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
